The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.50
Bid: 108.50
Ask: 110.00
Change: -1.00 (-0.91%)
Spread: 1.50 (1.382%)
Open: 109.50
High: 110.00
Low: 108.50
Prev. Close: 109.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 update

1 Apr 2020 07:00

RNS Number : 3226I
International Personal Finance Plc
01 April 2020
 

 

This announcement contains inside information

International Personal Finance plc

Covid-19 update

Further to our statement on 20 March 2020, the Company announces the following developments in connection with the Covid-19 pandemic.

Regulatory changes

Regulators and governments in a number of our markets have implemented, or are considering implementing, temporary consumer lending measures in response to the pandemic. These include debt repayment moratoriums and new or lower pricing limits.

In Poland a reduction in the cap on non-interest costs of credit for new lending has been approved for a period of one year, after which the cap will revert to historic levels. The flat level of the cap is reduced from 25% of the loan value to 15% and the additional variable cap from 30% to 6% per annum, with the aggregate total of the caps not to exceed 45% of the loan value.

In Hungary, the government has implemented a debt repayment moratorium for consumers until the end of the year; borrowers can opt out if they wish to continue to pay-down their loans. Additionally, for the same period, the maximum APR applicable to new consumer loans has been temporarily reduced to national bank base rate plus 5%.

In Romania, a debt repayment moratorium until the end of 2020 is available for customers not in default. Additionally, we understand that proposals for a 6 month debt repayment moratorium are being discussed in the Czech Republic.

Collections

Although largely unaffected through to the first half of March, collections in our home credit businesses are now being significantly adversely affected as tighter restrictions are imposed on the freedom of movement of individuals. Our immediate priority has been to safeguard the health and safety of our employees, agents and customers. In designing and implementing measures to achieve this, we have sought to mitigate, as far as reasonably possible, the impact on our operational and financial performance.

We have suspended agent visits to customers in Poland (except where requested by customers), Hungary and Romania. In Poland remote payment options are available and similar processes are being established in our other European Home Credit countries. In Hungary, pending discussions with the Hungarian National Bank on how to manage the implementation of the customer opt-out mechanism, we expect to recommence agent visits in the coming weeks. In Romania, we also plan to resume agent service shortly having enhanced protocols to protect the health of our agents and customers. Although we have seen limited impact in Mexico home credit to date, we are using lessons learned in Europe and taking actions now to protect our people, customers and the business in anticipation of this market being affected further by Covid-19. We have also tightened credit settings in IPF Digital which operates an end-to-end remote digital customer journey. 

Liquidity actions - credit issued, costs and capex

While it remains too early to quantify the potential financial impact of the pandemic on our businesses, the Group is taking a number of actions to protect liquidity through this period of uncertainty. Capital expenditure and 2020 salary increases (including those of our Executive Directors) are being deferred, costs are being reduced, and discretionary expenditure curtailed. Additionally, in response to reduced collections and in some cases tighter price caps, we have significantly restricted our lending across all of our businesses.

Funding position and dividend

In light of the uncertainty caused by the pandemic and its operational impact in the Group's markets, the Board believes that conserving cash and maximising financial flexibility is in the long term best interests of the business and its stakeholders. The Board has decided therefore to cancel the proposed annual final dividend payment of 7.8p per share which will result in a cash saving of £17.3 million. Accordingly, proposed resolution 4 in the notice of annual general shareholders meeting circulated to shareholders on 25 March 2020 recommending the final dividend will be withdrawn.

The Group has a strong balance sheet, and at the end of February 2020 had an equity to receivables capital ratio of 45% and headroom on undrawn debt facilities of £203 million. Whilst the duration and magnitude of pandemic related changes is difficult to predict, we have undertaken liquidity stress testing on the business under various scenarios to assess the impact of a further deterioration in collections performance. This analysis demonstrated that, in response to the pandemic related changes, we can manage cash flows by reducing lending volumes to retain adequate operational headroom against our debt facilities.

In the absence of any further material impact, we plan to provide an update with our Q1 trading statement on Thursday 30 April 2020.

 

Investor relations and media contacts

International Personal Finance plc

Rachel Moran

+44 (0)113 285 6798 / +44 (0)7760 167637

 

A copy of this statement can be found on our website at www.ipfin.co.uk.

Legal Entity Identifier: 213800II1O44IRKUZB59

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSDWEFFESSEDD
Date   Source Headline
2nd May 20241:53 pmRNSResults of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20246:01 pmRNSBoard Committee Membership Changes
1st May 20246:00 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.